These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 22406536)

  • 1. An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.
    Daniluk J; Liu Y; Deng D; Chu J; Huang H; Gaiser S; Cruz-Monserrate Z; Wang H; Ji B; Logsdon CD
    J Clin Invest; 2012 Apr; 122(4):1519-28. PubMed ID: 22406536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice.
    Maniati E; Bossard M; Cook N; Candido JB; Emami-Shahri N; Nedospasov SA; Balkwill FR; Tuveson DA; Hagemann T
    J Clin Invest; 2011 Dec; 121(12):4685-99. PubMed ID: 22056382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
    Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
    Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
    Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
    Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53.
    Swidnicka-Siergiejko AK; Gomez-Chou SB; Cruz-Monserrate Z; Deng D; Liu Y; Huang H; Ji B; Azizian N; Daniluk J; Lu W; Wang H; Maitra A; Logsdon CD
    Oncogene; 2017 Jun; 36(22):3149-3158. PubMed ID: 27991926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.
    Ling J; Kang Y; Zhao R; Xia Q; Lee DF; Chang Z; Li J; Peng B; Fleming JB; Wang H; Liu J; Lemischka IR; Hung MC; Chiao PJ
    Cancer Cell; 2012 Jan; 21(1):105-20. PubMed ID: 22264792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras.
    Gidekel Friedlander SY; Chu GC; Snyder EL; Girnius N; Dibelius G; Crowley D; Vasile E; DePinho RA; Jacks T
    Cancer Cell; 2009 Nov; 16(5):379-89. PubMed ID: 19878870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells.
    Bera A; Zhao S; Cao L; Chiao PJ; Freeman JW
    PLoS One; 2013; 8(12):e82282. PubMed ID: 24340014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype.
    Wang Z; Ali S; Banerjee S; Bao B; Li Y; Azmi AS; Korc M; Sarkar FH
    J Cell Physiol; 2013 Mar; 228(3):556-562. PubMed ID: 22806240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.
    Guerra C; Schuhmacher AJ; Cañamero M; Grippo PJ; Verdaguer L; Pérez-Gallego L; Dubus P; Sandgren EP; Barbacid M
    Cancer Cell; 2007 Mar; 11(3):291-302. PubMed ID: 17349585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF receptor is required for KRAS-induced pancreatic tumorigenesis.
    Ardito CM; Grüner BM; Takeuchi KK; Lubeseder-Martellato C; Teichmann N; Mazur PK; Delgiorno KE; Carpenter ES; Halbrook CJ; Hall JC; Pal D; Briel T; Herner A; Trajkovic-Arsic M; Sipos B; Liou GY; Storz P; Murray NR; Threadgill DW; Sibilia M; Washington MK; Wilson CL; Schmid RM; Raines EW; Crawford HC; Siveke JT
    Cancer Cell; 2012 Sep; 22(3):304-17. PubMed ID: 22975374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.
    Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ
    Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible and sustained upregulation of endothelin axis during oncogene-associated pancreatic inflammation and cancer.
    Gupta S; Prajapati A; Gulati M; Gautam SK; Kumar S; Dalal V; Talmon GA; Rachagani S; Jain M
    Neoplasia; 2020 Feb; 22(2):98-110. PubMed ID: 31923844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras activity levels control the development of pancreatic diseases.
    Ji B; Tsou L; Wang H; Gaiser S; Chang DZ; Daniluk J; Bi Y; Grote T; Longnecker DS; Logsdon CD
    Gastroenterology; 2009 Sep; 137(3):1072-82, 1082.e1-6. PubMed ID: 19501586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice.
    Salaymeh Y; Farago M; Sebban S; Shalom B; Pikarsky E; Katzav S
    Life Sci Alliance; 2020 May; 3(5):. PubMed ID: 32277014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas.
    Maier HJ; Wagner M; Schips TG; Salem HH; Baumann B; Wirth T
    Oncogene; 2013 May; 32(21):2690-5. PubMed ID: 22751123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation-Induced Cytidine Deaminase Contributes to Pancreatic Tumorigenesis by Inducing Tumor-Related Gene Mutations.
    Sawai Y; Kodama Y; Shimizu T; Ota Y; Maruno T; Eso Y; Kurita A; Shiokawa M; Tsuji Y; Uza N; Matsumoto Y; Masui T; Uemoto S; Marusawa H; Chiba T
    Cancer Res; 2015 Aug; 75(16):3292-301. PubMed ID: 26113087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer.
    Döppler H; Panayiotou R; Reid EM; Maimo W; Bastea L; Storz P
    Sci Rep; 2016 Sep; 6():33758. PubMed ID: 27649783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity.
    Chen NM; Neesse A; Dyck ML; Steuber B; Koenig AO; Lubeseder-Martellato C; Winter T; Forster T; Bohnenberger H; Kitz J; Reuter-Jessen K; Griesmann H; Gaedcke J; Grade M; Zhang JS; Tsai WC; Siveke J; Schildhaus HU; Ströbel P; Johnsen SA; Ellenrieder V; Hessmann E
    Gastroenterology; 2017 May; 152(6):1507-1520.e15. PubMed ID: 28188746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer.
    Saloman JL; Albers KM; Li D; Hartman DJ; Crawford HC; Muha EA; Rhim AD; Davis BM
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3078-83. PubMed ID: 26929329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.